In Redwood City, California, on July 31, 2025, Coherus Oncology, Inc. (Nasdaq: CHRS) disclosed the upcoming release of its second quarter 2025 financial results after the market closes on Thursday, August 7, 2025. A conference call and webcast will be led by Coherus’ management team at 5:00 p.m. EDT on August 7, 2025, to delve into the financial outcomes and deliver a comprehensive business overview.